Funding Opportunities: Urgent Competitive Revisions to IDeA and NARCH Programs for SARS-CoV-2 Surveillance Studies


UPDATE: The slides [PDF] and video from this webinar are now available.

We’re pleased to announce the availability of supplements to active INBRE (P20), COBRE (P20, P30), IDeA-CTR (U54), and NARCH (S06) awards for sequencing-based surveillance studies of the SARS-CoV-2 virus to track variants circulating in communities the IDeA and NARCH programs serve. The supplements will support SARS-CoV-2 viral genome sequencing and analysis studies. Projects are expected to expand on or collaborate with ongoing SARS-CoV-2 testing studies or programs in order to leverage resources and deliver results quickly to help address the urgent challenge.

Applications are due by March 31, 2021; see NOT-GM-21-031 for additional details.

If you have any questions about this supplement opportunity, please contact me.

Submit a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.